Attorneys in our Health Care & Life Sciences Group counsel health care providers, insurers, biopharmaceutical and device companies, and other entities throughout the country with respect to their most sophisticated legal challenges.

We strive to provide outstanding value to our clients while maintaining the highest professional standards in our work. Our success in doing so is evidenced by our selection as counsel by some of the largest, most highly regarded health care organizations in the country, as well as by smaller clients striving to make or expand their place in the health care market.

Our attorneys are consistently recognized by Chambers USA: America's Leading Lawyers for Business and The Best Lawyers in America for their dedication, superior skills, and practical savvy. We are a sought-after partner to health care businesses of all types and welcome the unique challenges and relationships each partnership brings.

We serve clients operating across the health care industry, including:

  • Academic medical centers
  • Hospitals and health care systems
  • Health centers (including FQHCs)
  • Multi-provider networks (ACOs, CINs, IDSs, IPAs, PHOs)
  • Universities and schools of medicine
  • Health plans and managed care companies
  • Pharmaceutical, biotechnology, and medical device companies
  • Physician groups
  • Health care data analysis companies
  • Commercial IRBs
  • Professional associations and societies
  • Ambulatory surgery centers
  • Health information technology companies
  • Research institutes
  • Laboratories (clinical, research, and others)
  • Government agencies
  • Research funders
  • Contract research organizations and other research service providers
  • Organ procurement organizations

We also provide a full range of strategic, regulatory, and government enforcement and litigation legal services. For more information on these services, please see the service line pages listed below.

Firm Highlights

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

News

Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...

Contact Verrill at (855) 307 0700